Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

02-08-2017 | Original Paper

Interactive Effects of Prenatal Antidepressant Exposure and Likely Gene Disrupting Mutations on the Severity of Autism Spectrum Disorder

Auteurs: Sean Ackerman, Sarah Schoenbrun, Caitlin Hudac, Raphael Bernier

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 11/2017

Abstract

To examine the interactive effects of two proposed risk factors which may contribute to symptom severity of Autism Spectrum Disorder (ASD): prenatal antidepressant exposure and likely gene-disrupting (LGD) mutations. Participants included 2748 individuals with ASD from the Simons Simplex Collection. We examined the effects of prenatal antidepressant exposure, maternal depression, presence of an LGD mutation and their interaction on ASD severity. We found a significant interactive effect between antidepressant exposure and the presence of an LGD mutation on ASD severity in the ADOS and ADI-R verbal communication domains. We consider a “two-hit” model in which one variable lays the foundation for an initial risk which is compounded by a second variable.

vorige artikel Structural and Pragmatic Language in Children with ASD: Longitudinal Impact on Anxiety and Externalizing Behaviors

volgende artikel Erratum to: Interactive Effects of Prenatal Antidepressant Exposure and Likely Gene Disrupting Mutations on the Severity of Autism Spectrum Disorder

American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders (5th edn.). Arlington, VA: American Psychiatric Publishing.CrossRef

Atladóttir HÓ, Henriksen, T. B., Schendel, D. E., et al. (2012). Autism after infection, febrile episodes, and antibiotic use during pregnancy: An exploratory study. Pediatrics, 130(6), e1447–e1454.CrossRefPubMedPubMedCentral

Boukhris, T., Sheehy, O., Mottron, L., et al. (2015). Antidepressant use during pregnancy and the risk of autism spectrum disorder in children. JAMA Pediatrics, 170(2), 117–124.CrossRef

Chaste, P., & Leboyer, M. (2012). Autism risk factors: Genes, environment, and gene-environment interactions. Dialogues in Clinical Neuroscience, 14(3), 281–292.PubMedPubMedCentral

Cooper, W. O., Willy, M. E., Pont, S. J., & Ray, W. A. (2007). Increasing use of antidepressants in pregnancy. American Journal of Obstetrics and Gynecology, 196(6), 544.e1-5.CrossRefPubMed

Croen, L. A., Grether, J. K., Yoshida, C. K., et al. (2011). Antidepressant use during pregnancy and childhood autism spectrum disorders. Archives of General Psychiatry, 68(11), 1104–1112.CrossRefPubMed

Fischbach, G. D., & Lord, C. (2010). The Simons Simplex Collection: A resource for identification of autism genetic risk factors. Neuron, 68(2), 192–195.CrossRefPubMed

Gardener, H., Spiegelman, D., & Buka, S. L. (2009). Prenatal risk factors for autism: Comprehensive meta-analysis. The British Journal of Psychiatry, 195(1), 7–14.CrossRefPubMedPubMedCentral

Gentile, S. (2015). Prenatal antidepressant exposure and the risk of autism spectrum disorders in children. Are we looking at the fall of Gods? Journal of Affective Disorders, 182, 132–137.CrossRefPubMed

Gidaya, N. B., Lee, B. K., Burstyn, I., et al. (2014). In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder. Journal of Autism and Developmental Disorders, 44(10), 2558–2567.CrossRefPubMed

Girirajan, S., Dennis, M. Y., Baker, C., et al. (2013). Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder. American Journal of Human Genetics, 92(2), 221–237.CrossRefPubMedPubMedCentral

Girirajan, S., & Eichler, E. E. (2010). Phenotypic variability and genetic susceptibility to genomic disorders. Human Molecular Genetics, 19(R2), R176–R187.CrossRefPubMedPubMedCentral

Girirajan, S., Rosenfeld, J. A., Coe, B. P., et al. (2012). Phenotypic heterogeneity of genomic disorders and rare copy-number variants. The New England Journal of Medicine, 367(14), 1321–1331.CrossRefPubMedPubMedCentral

Girirajan, S., Rosenfeld, J. A., Cooper, G. M., Antonacci, F., et al. (2010). A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nature Genetics, 42, 203–209.CrossRefPubMedPubMedCentral

Gotham, K., Pickles, A., & Lord, C. (2009). Standardizing ADOS scores for a measure of severity in autism spectrum disorders. Journal of Autism and Developmental Disorders, 39(5), 693–705.CrossRefPubMed

Hanson, E., Bernier, R., Porche, K., et al. (2015). Simons Variation in Individuals Project Consortium. The cognitive and behavioral phenotype of the 16p11.2 deletion in a clinically ascertained population. Biological Psychiatry, 77(9), 785–793.CrossRefPubMed

Harrington, R. A., Lee, L. C., Crum, R. M., et al. (2014). Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay. Pediatrics 133(5), 1241–1248.CrossRef

Hus, V., Gotham, K., & Lord, C. (2014). Standardizing ADOS domain scores: Separating severity of social affect and restricted and repetitive behaviors. Journal of Autism and Developmental Disorders, 44(10), 2400–2412.CrossRefPubMedPubMedCentral

Hviid, A., Melbye, M., & Pasternak, B. (2013). Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. The New England Journal of Medicine, 369(25), 2406–2415.CrossRefPubMed

Iossifov I, O’Roak BJ, Sanders SJ, et al. (2014). The contribution of de novo coding mutations to autism spectrum disorder. Nature 515(7526):216–221.CrossRefPubMedPubMedCentral

Kalkbrenner, A. E., Windham, G. C., Serre, M. L., et al. (2015). Particulate matter exposure, prenatal and postnatal windows of susceptibility, and autism spectrum disorders. Epidemiology 26(1), 30–42.CrossRefPubMed

Krumm, N., O’Roak, B. J., Shendure, J., et al. (2014). A de novo convergence of autism genetics and molecular neuroscience. Trends in Neurosciences, 37(2), 95–105.CrossRefPubMed

Landrigan, P. J. (2010). What causes autism? Exploring the environmental contribution. Current Opinion in Pediatrics 22(2), 219–225.CrossRefPubMed

Leblond, C. S., Heinrich, J., Delorme, R., et al. (2012). Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genetics, 8(2), e1002521.CrossRefPubMedPubMedCentral

Lord, C., Risi, S., Lambrecht, L., et al. (2000). The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. Journal of Autism and Developmental Disorders, 30(3), 205–223.CrossRefPubMed

Lord, C., Rutter, M., & Le Couteur, A. (1994). Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24(5), 659–685.CrossRefPubMed

Man, K. K., Tong, H. H., Wong, L. Y., et al. (2015). Exposure to selective serotonin reuptake inhibitors during pregnancy and risk of autism spectrum disorder in children: A systematic review and meta-analysis of observational studies. Neuroscience and Biobehavioral Reviews, 49, 82–89.CrossRefPubMed

Mazina, V., et al. (2015a). Interactive effects of copy number variation and maternal infection on autism impairment. Journal of Developmental and Behavioral Pediatrics: JDBP, 36(2), 61–67.CrossRefPubMedPubMedCentral

Mazina, V., Gerdts, J., Trinh, S., et al. (2015b). Epigenetics of autism-related impairment: Copy number variation and maternal infection. Journal of Developmental and Behavioral Pediatrics: JDBP, 36(2), 61–67.CrossRefPubMedPubMedCentral

Mitchell, A. A., Gilboa, S. M., Werler, M. M., et al. (2011). Medication use during pregnancy, with particular focus on prescription drugs: 1976–2008. American Journal of Obstetrics and Gynecology, 205(51), e1.

O’Roak, B. J., Vives, L., Girirajan, S., et al. (2012). Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature, 485(7397), 246–250.CrossRefPubMedPubMedCentral

Rai D, Lee BK, Dalman C, et al. (2013). Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: Population based case-control study. BMJ 346, f2059.CrossRefPubMedPubMedCentral

Sanders, S. J., Ercan-Sencicek, A. G., Hus, V., et al. (2011). Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron, 70(5), 863–885.CrossRefPubMedPubMedCentral

Sanders, S. J., He, X., Willsey, A. J., Ercan-Sencicek, A. G., et al. (2015). Insights into autism spectrum disorder genomic architecture and biology from 71 Risk Loci. Neuron, 87(6), 1215–1233.CrossRefPubMedPubMedCentral

Shelton, J. F., Geraghty, E. M., Tancredi, D. J., et al. (2014). Neurodevelopmental disorders and prenatal residential proximity to agricultural pesticides: The CHARGE study. Environmental Health Perspectives, 122(10), 1103–1109.PubMedPubMedCentral

Shishido, E., Aleksic, B., & Ozaki, N. (2014). Copy-number variation in the pathogenesis of autism spectrum disorder. Psychiatry and Clinical Neurosciences, 68(2), 85–95.CrossRefPubMed

Sorensen, M. J., Gronborg, T. K., Christensen, J., et al. (2013). Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clinical Epidemiology 15(5), 449–459.CrossRef

Stefansson, H., Meyer-Lindenberg, A., Steinberg, S., et al. (2014). CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature, 505(7483):361.CrossRefPubMed

Stessman, H. A., Xiong, B., Coe, B. P., et al. (2017). Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases. Nature Genetics, 49(4), 515–526.CrossRefPubMedPubMedCentral

Viktorin, A., Uher, R., Reichenberg, A., et al. (2017). Autism risk following antidepressant medication during pregnancy. Psychological Medicine, 22, 1–10.CrossRef

Weiss, L. A., Shen, Y., Korn, J. M., et al. (2008). Association between microdeletion and microduplication at 16p11.2 and autism. The New England Journal of Medicine, 358(7), 667–675.CrossRefPubMed

Zimmerberg, B., & Germeyan, S. C. (2015). Effects of neonatal fluoxetine exposure on behavior across development in rats selectively bred for an infantile affective trait. Developmental Psychobiology, 57(2), 141–152.CrossRefPubMed

Zufferey, F., Sherr, E. H., Beckmann, N. D., et al. (2012). A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders. Journal of Medical Genetics, 49(10), 660–668.CrossRefPubMedPubMedCentral

Titel: Interactive Effects of Prenatal Antidepressant Exposure and Likely Gene Disrupting Mutations on the Severity of Autism Spectrum Disorder
Auteurs: Sean Ackerman
Sarah Schoenbrun
Caitlin Hudac
Raphael Bernier
Publicatiedatum: 02-08-2017
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 11/2017
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-017-3246-6

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 11/2017

The Actions and Feelings Questionnaire in Autism and Typically Developed Adults

Structural and Pragmatic Language in Children with ASD: Longitudinal Impact on Anxiety and Externalizing Behaviors

Cognitive Behaviour Therapy Versus a Counselling Intervention for Anxiety in Young People with High-Functioning Autism Spectrum Disorders: A Pilot Randomised Controlled Trial

Responding to Other People’s Direct Gaze: Alterations in Gaze Behavior in Infants at Risk for Autism Occur on Very Short Timescales

Association Between Autistic Traits in Preschool Children and Later Emotional/Behavioral Outcomes

Brief Report: What Happens When I Can No Longer Support My Autistic Relative? Worries About the Future for Family Members of Autistic Adults